Cell Killing And Resistance In Pre-Operative Breast Cancer Chemotherapy

April 2017

Cancer

Country of origin: USA

Despite the recent development of technologies giving detailed images of tumours in vivo, direct or indirect ways to measure how many cells are actually killed by a treatment or are resistant to it are still beyond our reach.

Researchers designed a simple model of tumour progression during treatment, based on descriptions of the key phenomena of proliferation, quiescence, cell killing and resistance, and giving as output the macroscopically measurable tumour volume and growth fraction. The model was applied to a database of the time course of volumes of breast cancer in patients undergoing pre-operative chemotherapy, for which the initial estimate of proliferating cells by the measure of the percentage of Ki67-positive cells was available.

The analysis recognises different patterns of response to treatment. In one subgroup of patients the fitting implied drug resistance. In another subgroup there was a shift to higher sensitivity during the therapy. In the subgroup of patients where killing of cycling cells had the highest score, the drugs showed variable efficacy against quiescent cells.

The research concludes that the approach was feasible, providing items of information not otherwise available. Additional data, particularly sequential Ki67 measures, could be added to the system, potentially reducing uncertainty in estimates of parameter values.

The complete article is available as a provisional PDF.

Resources

Institute of Cancer Research February 2019 The Institute of Cancer Research (ICR) new website is designed to serve the needs of a wide audience: the international...
Researchers in bowel cancer discovery February 2019 Scientists have discovered how genes cause bowel cancer cells to become resistant to treatments used against the disease....
The Role And Value Of Specialist Nurses In Prostate Cancer Care January 2019 Specialist nurses may play an important role in helping to improve the experiences of patients with prostate cancer,...
Transplantation of organs from donors with a history of cancer January 2019 The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) reviewed evidence including the outcomes of...
inPractice® Oncology. January 2019 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Prostate cancer report January 2019 Prostate Cancer UK has launched a new report, 'Men United v Prostate Cancer: Five inequalities, five solutions', and are...
Website Helps Cancer Patients With Fertility Preservation December 2018 A website to help cancer patients learn more about how they can preserve their ability to have children has been launched...
Manual for Cancer Services: Chemotherapy Measures November 2018 Following a three month consultation period the revised chemotherapy measures were published recently for inclusion in the...
QuitMedKit counseling and treatment of tobacco dependence October 2018 Tobacco use remains the number-one preventable cause of morbidity and mortality in the United States and worldwide. So it’s...
Sublux radiology app for all medical providers October 2018 What apps are available that teach the basics of plain radiography for more than just chest X-rays and ortho trauma? Are...
Search by Keyword